Fatemeh Karami‐Tehrani
- Physiology top 1%
- Adenosine and Purinergic Signaling 7
- Nitric Oxide and Endothelin Effects 4
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents 4
-
- Cell death mechanisms and regulation 9
-
- Cancer-related Molecular Pathways 4
-
- Estrogen and related hormone effects 5
-
- Synthesis and Characterization of Heterocyclic Compounds 3
-
- Computational Drug Discovery Methods 3
- Co-authors
- Siamak SalamiMahmoud AghaeiFaranak FallahianMohammad HashemiMorteza AtriZahra ShahsavariMojtaba PanjehpourSaeid Ghavami
- Cited by
- PhysiologyToxicologyCancer Research
- Journals
- SHILAP Revista de lepidopterología (1 paper)Journal of Leukocyte Biology (1 paper)The International Journal of Biochemistry & Cell Biology (1 paper)
In The Last Decade
Fatemeh Karami‐Tehrani
27 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 104
- Physiology 215
- Toxicology 74
- Cancer Research 151
- Molecular Biology 648
- Oncology 205
Countries citing papers authored by Fatemeh Karami‐Tehrani
This map shows the geographic impact of Fatemeh Karami‐Tehrani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatemeh Karami‐Tehrani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatemeh Karami‐Tehrani more than expected).
Fields of papers citing papers by Fatemeh Karami‐Tehrani
This network shows the impact of papers produced by Fatemeh Karami‐Tehrani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatemeh Karami‐Tehrani. The network helps show where Fatemeh Karami‐Tehrani may publish in the future.
Co-authorship network
The 21 scholars most cited alongside Fatemeh Karami‐Tehrani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 7 | |
| 2 | 2015 | 52 | |
| 3 | 2015 | 41 | |
| 4 | 2014 | 46 | |
| 5 | 2012 | 51 | |
| 6 | 2012 | 17 | |
| 7 | 2012 | 28 | |
| 8 | 2011 | 61 | |
| 9 | 2011 | 26 | |
| 10 | 2011 | 95 | |
| 11 | 2011 | 53 | |
| 12 | 2010 | 34 | |
| 13 | 2010 | 36 | |
| 14 | 2007 | 45 | |
| 15 | 2005 | 54 | |
| 16 | 2005 | 49 | |
| 17 | CYTOTOXICITY EFFECT OF CLADRIBINE ON THE MCF-7 HUMAN BREAST CANCER CELL LINE | 2004 | 9 |
| 18 | 2004 | 29 | |
| 19 | 2003 | 86 | |
| 20 | 2001 | 4 |
About Fatemeh Karami‐Tehrani
Fatemeh Karami‐Tehrani is a scholar working on Physiology, Toxicology and Molecular Biology, having authored 27 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (9 papers), Adenosine and Purinergic Signaling (7 papers), Estrogen and related hormone effects (5 papers), Bioactive Compounds and Antitumor Agents (4 papers), Nitric Oxide and Endothelin Effects (4 papers), Cancer-related Molecular Pathways (4 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers) and Computational Drug Discovery Methods (3 papers). The work is most often cited by research in Physiology (215 citations), Toxicology (74 citations) and Cancer Research (151 citations). Fatemeh Karami‐Tehrani has collaborated with scholars based in Iran, Canada and Ukraine. Frequent co-authors include Siamak Salami, Mahmoud Aghaei, Faranak Fallahian, Mohammad Hashemi, Morteza Atri, Zahra Shahsavari, Mojtaba Panjehpour, Saeid Ghavami, Mojtaba Panjehpour and Clemens Sorg. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of Leukocyte Biology and The International Journal of Biochemistry & Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.